Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Diamedica Therapeutics Inc (NQ: DMAC )

1.780 +0.090 (+5.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 83,436
Open 1.650
Bid (Size) 1.690 (2)
Ask (Size) 1.810 (2)
Prev. Close 1.690
Today's Range 1.650 - 1.875
52wk Range 1.150 - 4.820
Shares Outstanding 26,443,067
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
DiaMedica Therapeutics to Report Second Quarter 2022 Financial Results and Provide a Business Update August 11, 2022
From DiaMedica Therapeutics Inc.
Via Business Wire
DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022
From DiaMedica Therapeutics Inc.
Via Business Wire

Performance

YTD
-54.12%
-54.12%
1 Month
+36.92%
+36.92%
3 Month
-30.74%
-30.74%
6 Month
-36.88%
-36.88%
1 Year
-47.65%
-47.65%

More News

Read More
3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More
Via Benzinga
Nasdaq Surges 250 Points; Crude Oil Rises Sharply
Via Benzinga
FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial - Read Why
Via Benzinga
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue
Via Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
Via Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199
From DiaMedica Therapeutics
Via Business Wire
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Via Benzinga
DiaMedica Therapeutics to Attend the 19th Annual Craig-Hallum Institutional Investor Conference Wednesday, June 1, 2022
From DiaMedica Therapeutics
Via Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results
From DiaMedica Therapeutics Inc.
Via Business Wire
Earnings Preview For DiaMedica Therapeutics
Via Benzinga
DiaMedica Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update May 5, 2022
From DiaMedica Therapeutics Inc.
Via Business Wire
DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results
From DiaMedica Therapeutics Inc.
Via Business Wire
Earnings Scheduled For March 14, 2022
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Via Benzinga
DiaMedica Therapeutics Earnings Preview
Via Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.